Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(18):1517-1522; doi:10.1093/jnci/92.18.1517
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Peel, D. J.
Right arrow Articles by Anton-Culver, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peel, D. J.
Right arrow Articles by Anton-Culver, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 18, 1517-1522, September 20, 2000
© 2000 Oxford University Press


REPORTS

Characterization of Hereditary Nonpolyposis Colorectal Cancer Families From a Population-Based Series of Cases

David J. Peel, Argyrios Ziogas, Edward A. Fox, Maureen Gildea, Beth Laham, Enedina Clements, Richard D. Kolodner, Hoda Anton-Culver

Affiliations of authors: D. J. Peel, A. Ziogas, M. Gildea, B. Laham, E. Clements, H. Anton-Culver, Epidemiology Division, Department of Medicine, University of California, Irvine; E. A. Fox, Dana-Farber Cancer Institute, Boston, MA; R. D. Kolodner, Ludwig Institute for Cancer Research, University of California School of Medicine, San Diego.

Correspondence to: Hoda Anton-Culver, Ph.D., Epidemiology Division, Department of Medicine, 224 Irvine Hall, University of California, Irvine, Irvine, CA 92697-7550 (e-mail: hantoncu{at}uci.edu).

Background: The incidence of hereditary nonpolyposis colon cancer (HNPCC) in the general population is not well defined because of the lack of large population-based studies. We characterized the incidence of HNPCC in a large, population-based cohort of colorectal cancer probands and analyzed the location of colorectal tumors. Methods: Of the participating 1134 probands from three counties in Southern California, 907 had a negative family history of colorectal cancer and 227 had a positive family history of colorectal cancer. In addition, 11 referral case subjects with HNPCC were used to study mutation frequencies in two mismatch repair genes (MSH2 and MLH1) and microsatellite instability. All statistical tests were two-sided. Results: Among the probands diagnosed in Orange County during 1994 (population-based sample, all ages), five were consistent with the Amsterdam criteria for HNPCC (0.9%; 95% confidence interval [CI] = 0.3%–2.1%). Among probands diagnosed at less than 65 years of age—from the wider three-county area and a longer time span–16 (2.1%; 95% CI = 1.2%–3.4%) had a clinical history consistent with the Amsterdam criteria for HNPCC. Five (approximately 45%) of 11 of the referral HNPCC case subjects had a mutation in MSH2 or MLH1 and also showed microsatellite instability. The family members of case subjects with mutations tended to show an earlier age at diagnosis of HNPCC and more multiple primary cancers than those of case subjects without detectable mutations. Many of the known characteristics of HNPCC, including the presence of ureteral and endometrial cancers, were seen in both sets of families. The previously reported proximal location of colorectal tumors in HNPCC kindreds was not seen in the population-based dataset but was similar to the location reported in the referral cases. Conclusions: On the basis of our data, we believe that the prevalence of HNPCC in the general population is likely to be closer to 1% than to 5%. Furthermore, our study suggests that some previously reported characteristics of HNPCC, such as the proximal location of tumors in the syndrome, may not always hold true in a population-based sample.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. A. Zell, A. Ziogas, N. Ignatenko, J. Honda, N. Qu, A. S. Bobbs, S. L. Neuhausen, E. W. Gerner, and H. Anton-Culver
Associations of a Polymorphism in the Ornithine Decarboxylase Gene with Colorectal Cancer Survival
Clin. Cancer Res., October 1, 2009; 15(19): 6208 - 6216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Zell, J. Honda, A. Ziogas, and H. Anton-Culver
Survival After Colorectal Cancer Diagnosis Is Associated with Colorectal Cancer Family History
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3134 - 3140.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. N. Poynter, K. D. Siegmund, D. J. Weisenberger, T. I. Long, S. N. Thibodeau, N. Lindor, J. Young, M. A. Jenkins, J. L. Hopper, J. A. Baron, et al.
Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3208 - 3215.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Ewart-Toland, Q. Dai, Y.-T. Gao, H. Nagase, M. G. Dunlop, S. M. Farrington, R. A. Barnetson, H. Anton-Culver, D. Peel, A. Ziogas, et al.
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types
Carcinogenesis, August 1, 2005; 26(8): 1368 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. J Khoury, R. Millikan, J. Little, and M. Gwinn
The emergence of epidemiology in the genomics age
Int. J. Epidemiol., October 1, 2004; 33(5): 936 - 944.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. C. Kim, K. H. Lee, I. H. Ka, K. H. Koo, S. A. Roh, H. C. Kim, C. S. Yu, T. W. Kim, H. M. Chang, G. Y. Gong, et al.
Characterization of Mutator Phenotype in Familial Colorectal Cancer Patients Not Fulfilling Amsterdam Criteria
Clin. Cancer Res., September 15, 2004; 10(18): 6159 - 6168.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Umar, C. R. Boland, J. P. Terdiman, S. Syngal, A. d. l. Chapelle, J. Ruschoff, R. Fishel, N. M. Lindor, L. J. Burgart, R. Hamelin, et al.
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
J Natl Cancer Inst, February 18, 2004; 96(4): 261 - 268.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. L. Frazier, L. Xi, J. Zong, N. Viscofsky, A. Rashid, E. F. Wu, P. M. Lynch, C. I. Amos, and J.-P. J. Issa
Association of the CpG Island Methylator Phenotype with Family History of Cancer in Patients with Colorectal Cancer
Cancer Res., August 15, 2003; 63(16): 4805 - 4808.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. W. Hadley, J. Jenkins, E. Dimond, K. Nakahara, L. Grogan, D. J. Liewehr, S. M. Steinberg, and I. Kirsch
Genetic Counseling and Testing in Families With Hereditary Nonpolyposis Colorectal Cancer
Arch Intern Med, March 10, 2003; 163(5): 573 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A Wagner, C Tops, J T Wijnen, K Zwinderman, C van der Meer, M Kets, M F Niermeijer, J G M Klijn, A Tibben, H F A Vasen, et al.
Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation
J. Med. Genet., November 1, 2002; 39(11): 833 - 837.
[Full Text] [PDF]


Home page
Arch SurgHome page
C. P. Theuer, B. S. Campbell, D. J. Peel, F. Lin, P. Carpenter, A. Ziogas, and J. A. Butler
Microsatellite Instability in Japanese vs European American Patients With Gastric Cancer
Arch Surg, August 1, 2002; 137(8): 960 - 966.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C P Strassburg, A Vogel, S Kneip, R H Tukey, and M P Manns
Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer
Gut, June 1, 2002; 50(6): 851 - 856.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H S Evans, H Moller, D Robinson, C M Lewis, C M J Bell, and S V Hodgson
The risk of subsequent primary cancers after colorectal cancer in southeast England
Gut, May 1, 2002; 50(5): 647 - 652.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Andermann, I. Thiffault, N. Wong, P. Gordon, E. MacNamara, G. Chong, W. Foulkes, A. Percesepe, M. Ponz de Leon, and P. Peltomaki
Multimodal Molecular Screening Is Required to Improve the Sensitivity of MLH1 and MSH2 Mutation Analysis
J. Clin. Oncol., March 15, 2002; 20(6): 1705 - 1707.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Young, L. A. Simms, K. G. Biden, C. Wynter, V. Whitehall, R. Karamatic, J. George, J. Goldblatt, I. Walpole, S.-A. Robin, et al.
Features of Colorectal Cancers with High-Level Microsatellite Instability Occurring in Familial and Sporadic Settings : Parallel Pathways of Tumorigenesis
Am. J. Pathol., December 1, 2001; 159(6): 2107 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Liu, H. Yan, S. Kuismanen, A. Percesepe, M.-L. Bisgaard, M. Pedroni, P. Benatti, K. W. Kinzler, B. Vogelstein, M. Ponz de Leon, et al.
The Role of hPMS1 and hPMS2 in Predisposing to Colorectal Cancer
Cancer Res., November 1, 2001; 61(21): 7798 - 7802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J R Jass, K Shitoh, F Konishi, T Furukawa, H Nagai, M Miyaki, T Iijima, and T Tsukamoto
Microsatellite unstable colorectal cancer
J. Clin. Pathol., July 1, 2001; 54(7): 573 - 574.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. G. Evans, C. L. Wu, S. Walsh, I. Hansen, L. Verma, C. Robinson, R. Kingston, and E. R. Maher
Re: Characterization of Hereditary Nonpolyposis Colorectal Cancer Families From a Population-Based Series of Cases
J Natl Cancer Inst, May 2, 2001; 93(9): 716 - 717.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Hemminki
Re: Characterization of Hereditary Nonpolyposis Colorectal Cancer Families From a Population-Based Series of Cases
J Natl Cancer Inst, April 18, 2001; 93(8): 651 - 651.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.